NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
GBG Forschungs GmbH
Zhejiang Cancer Hospital
Peking University
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Hoffmann-La Roche
Tianjin Medical University Cancer Institute and Hospital